Scinai Immunotherapeutics (SCNI) Net Cash Flow Growth (1y) (2019 - 2024)
Scinai Immunotherapeutics (SCNI) Net Cash Flow Growth (1y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 198.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 467.41% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14,223.53% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 163.33% |
| Sep 30, 2024 | 9.28% |
| Jun 30, 2024 | 45.77% |
| Mar 31, 2024 | 52.20% |
| Dec 31, 2023 | -69.06% |
| Sep 30, 2023 | -13.12% |
| Jun 30, 2023 | 22.86% |
| Mar 31, 2023 | -88.50% |
| Dec 31, 2022 | -112.48% |
| Sep 30, 2022 | 72.43% |
| Jun 30, 2022 | 49.40% |
| Mar 31, 2022 | -114.28% |
| Dec 31, 2021 | 143.48% |
| Sep 30, 2021 | 47.91% |
| Jun 30, 2021 | -167.80% |
| Dec 31, 2020 | -208.98% |
| Sep 30, 2020 | -120.32% |
| Mar 31, 2019 | 0.37% |